Ok some rational thoughts - haven't posted on NWE for a while,...

Ok some rational thoughts - haven't posted on NWE for a while, just been following.

Number one:
Wait period
upside - time <3 months
downside - EPA decide to make an assesement so we are looking at 3 months (to decide) + assesement time (?)

Number two:
I thought that we would have received some core sample results in the near future. This will appease the market.

Number three:
The domestic demand for energy (particularly regional) will continue to increase. If we are delayed three to six months it may fair our share price better during testing than in the current market.

Norwest is a good outfit with a history of complying with DMP. Listed for ~14 years and we have some heavy hitter partners (we aren't viewed as some cowboys who want to come in and start pumping chemicals into the ground). So this fairs well for us. The EPAs bureaucracy is going to require management though. They will need to tick wll their boxes and run their dd on our plans.

So for all the long term investors this really isnt such a big deal. If Arrowsmith is commercial a share price appreciation and realisation of the value of the assets is going to take some time, so what's three months.

However, If you are trading on Norwest, you've been stung.

Number 4: The release was actually very positive on our potential asset. They probably have a better idea of the 'picture' than us but not at the stage ready to be announced, ie results/fraccing plan so that was assuring to read.

Number 5: Expect a CR late this year. Highly likely.

DYOR CG - good luck investors